Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft Rejection | 46 | 2024 | 4499 | 3.690 |
Why?
|
Transplantation Tolerance | 17 | 2025 | 640 | 3.060 |
Why?
|
Isoantigens | 16 | 2022 | 562 | 2.570 |
Why?
|
Transplantation, Homologous | 47 | 2024 | 4860 | 2.120 |
Why?
|
T-Lymphocytes | 42 | 2024 | 10261 | 2.000 |
Why?
|
Skin Transplantation | 19 | 2020 | 1098 | 1.950 |
Why?
|
Immune Tolerance | 25 | 2022 | 2324 | 1.430 |
Why?
|
Chimerism | 9 | 2022 | 154 | 1.400 |
Why?
|
Exosomes | 3 | 2021 | 421 | 1.370 |
Why?
|
Antigen Presentation | 13 | 2020 | 1250 | 1.160 |
Why?
|
Histocompatibility Antigens | 10 | 2024 | 477 | 1.150 |
Why?
|
Immunologic Memory | 11 | 2020 | 1375 | 1.140 |
Why?
|
Bone Marrow Transplantation | 15 | 2025 | 2729 | 1.050 |
Why?
|
Graft Survival | 21 | 2025 | 3890 | 1.050 |
Why?
|
Kidney Transplantation | 15 | 2025 | 4270 | 1.010 |
Why?
|
Antigen-Presenting Cells | 9 | 2024 | 962 | 1.000 |
Why?
|
Heart Transplantation | 18 | 2025 | 3310 | 0.970 |
Why?
|
Major Histocompatibility Complex | 13 | 2015 | 879 | 0.860 |
Why?
|
Corneal Transplantation | 7 | 2013 | 315 | 0.850 |
Why?
|
Histocompatibility Antigens Class II | 12 | 2010 | 1441 | 0.840 |
Why?
|
Interleukin-2 | 13 | 2016 | 1896 | 0.820 |
Why?
|
Macaca fascicularis | 14 | 2025 | 907 | 0.800 |
Why?
|
Mice, Inbred BALB C | 30 | 2020 | 6220 | 0.770 |
Why?
|
Autoantigens | 11 | 2018 | 883 | 0.710 |
Why?
|
CD8-Positive T-Lymphocytes | 13 | 2020 | 4642 | 0.640 |
Why?
|
Histocompatibility Antigens Class I | 12 | 2009 | 1365 | 0.630 |
Why?
|
Lymphocyte Depletion | 4 | 2015 | 605 | 0.630 |
Why?
|
CD4-Positive T-Lymphocytes | 17 | 2020 | 4405 | 0.600 |
Why?
|
Transplantation Immunology | 3 | 2011 | 541 | 0.570 |
Why?
|
Transplantation Chimera | 6 | 2015 | 609 | 0.550 |
Why?
|
H-2 Antigens | 4 | 2010 | 359 | 0.550 |
Why?
|
Lymphocyte Activation | 19 | 2013 | 5501 | 0.540 |
Why?
|
Animals | 95 | 2025 | 168764 | 0.530 |
Why?
|
Isoantibodies | 4 | 2015 | 681 | 0.520 |
Why?
|
Antigens, CD20 | 1 | 2015 | 198 | 0.470 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2016 | 266 | 0.460 |
Why?
|
Tissue Donors | 4 | 2025 | 2395 | 0.450 |
Why?
|
Transplantation Conditioning | 10 | 2016 | 1635 | 0.450 |
Why?
|
Dendritic Cells | 5 | 2013 | 2747 | 0.450 |
Why?
|
Peptides | 12 | 2001 | 4331 | 0.440 |
Why?
|
Receptors, Antigen, T-Cell | 7 | 2010 | 2570 | 0.430 |
Why?
|
Self Tolerance | 5 | 2006 | 119 | 0.430 |
Why?
|
Interferon-gamma | 17 | 2016 | 3160 | 0.430 |
Why?
|
T-Lymphocyte Subsets | 9 | 2014 | 1811 | 0.420 |
Why?
|
Mice | 59 | 2021 | 81819 | 0.420 |
Why?
|
Lymphoid Tissue | 1 | 2014 | 444 | 0.420 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 414 | 0.390 |
Why?
|
Free Radical Scavengers | 2 | 2006 | 212 | 0.380 |
Why?
|
Th1 Cells | 9 | 2009 | 1039 | 0.370 |
Why?
|
Autoimmunity | 8 | 2009 | 1354 | 0.370 |
Why?
|
Myosins | 3 | 2002 | 408 | 0.360 |
Why?
|
Th2 Cells | 9 | 2009 | 1075 | 0.360 |
Why?
|
Transplants | 1 | 2013 | 208 | 0.360 |
Why?
|
Mice, Inbred C57BL | 26 | 2020 | 22332 | 0.320 |
Why?
|
Immunomodulation | 1 | 2013 | 547 | 0.310 |
Why?
|
B-Lymphocytes | 4 | 2020 | 4778 | 0.310 |
Why?
|
T-Lymphocytes, Regulatory | 8 | 2025 | 3111 | 0.300 |
Why?
|
CD40 Ligand | 7 | 2013 | 528 | 0.290 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2000 | 825 | 0.290 |
Why?
|
Mice, Inbred CBA | 5 | 2010 | 439 | 0.280 |
Why?
|
Cardiac Myosins | 3 | 2018 | 128 | 0.280 |
Why?
|
Maternal-Fetal Exchange | 3 | 2020 | 453 | 0.270 |
Why?
|
Organ Transplantation | 1 | 2016 | 1174 | 0.250 |
Why?
|
Antibodies, Monoclonal | 8 | 2015 | 9249 | 0.240 |
Why?
|
Killer Cells, Natural | 2 | 2012 | 2210 | 0.240 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5753 | 0.240 |
Why?
|
Epitopes | 8 | 2002 | 2523 | 0.230 |
Why?
|
Mice, Inbred C3H | 3 | 2015 | 914 | 0.230 |
Why?
|
Bone Marrow Cells | 3 | 2013 | 2412 | 0.220 |
Why?
|
Manganese | 1 | 2006 | 395 | 0.220 |
Why?
|
Adaptation, Physiological | 2 | 2007 | 1308 | 0.210 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2495 | 0.200 |
Why?
|
Diphtheria Toxin | 2 | 2014 | 253 | 0.200 |
Why?
|
Peptide Fragments | 9 | 2003 | 5125 | 0.200 |
Why?
|
HLA Antigens | 2 | 1998 | 1339 | 0.190 |
Why?
|
Adaptive Immunity | 2 | 2020 | 734 | 0.180 |
Why?
|
Luminescent Measurements | 6 | 1991 | 341 | 0.180 |
Why?
|
Sarcoma, Experimental | 1 | 2000 | 116 | 0.170 |
Why?
|
Skin | 1 | 2013 | 4489 | 0.160 |
Why?
|
Amino Acid Sequence | 11 | 2014 | 13400 | 0.160 |
Why?
|
Mice, Transgenic | 5 | 2015 | 9550 | 0.160 |
Why?
|
Immunosuppressive Agents | 6 | 2015 | 4209 | 0.160 |
Why?
|
Molecular Sequence Data | 12 | 2014 | 17594 | 0.150 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2140 | 0.150 |
Why?
|
Autoimmune Diseases | 4 | 2010 | 2226 | 0.150 |
Why?
|
Swine, Miniature | 3 | 2016 | 971 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2006 | 2942 | 0.140 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2014 | 305 | 0.140 |
Why?
|
Ethylenediamines | 1 | 1997 | 47 | 0.140 |
Why?
|
Vimentin | 1 | 2018 | 258 | 0.140 |
Why?
|
Alopecia Areata | 1 | 1999 | 129 | 0.140 |
Why?
|
Interleukin-4 | 3 | 2011 | 1162 | 0.140 |
Why?
|
Models, Immunological | 2 | 2010 | 517 | 0.130 |
Why?
|
Kidney Function Tests | 2 | 2015 | 683 | 0.130 |
Why?
|
Lung Transplantation | 2 | 2015 | 1311 | 0.120 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2013 | 58 | 0.120 |
Why?
|
Biological Factors | 1 | 1995 | 155 | 0.120 |
Why?
|
Antibodies, Neoplasm | 2 | 2006 | 282 | 0.120 |
Why?
|
Macrophage Activation | 2 | 1988 | 552 | 0.110 |
Why?
|
Interleukin-15 | 2 | 2012 | 186 | 0.110 |
Why?
|
Papio | 1 | 2016 | 671 | 0.110 |
Why?
|
Lymphocyte Transfusion | 1 | 2015 | 236 | 0.110 |
Why?
|
Organ Specificity | 2 | 2013 | 1965 | 0.110 |
Why?
|
Myocardium | 3 | 2012 | 4760 | 0.110 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 682 | 0.110 |
Why?
|
Swine | 4 | 2022 | 5988 | 0.110 |
Why?
|
Receptors, Fc | 2 | 1987 | 536 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 1997 | 644 | 0.110 |
Why?
|
Postoperative Complications | 2 | 2015 | 15747 | 0.110 |
Why?
|
Mice, Inbred Strains | 6 | 2003 | 1770 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2020 | 3081 | 0.100 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 220 | 0.100 |
Why?
|
Adolescent Psychiatry | 1 | 1995 | 166 | 0.100 |
Why?
|
Psychophysiologic Disorders | 1 | 1995 | 222 | 0.100 |
Why?
|
Transplantation, Isogeneic | 3 | 2002 | 251 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2009 | 3807 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 4 | 2014 | 3737 | 0.100 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2015 | 746 | 0.100 |
Why?
|
Mice, Inbred A | 4 | 2004 | 244 | 0.100 |
Why?
|
Immunotoxins | 1 | 2012 | 177 | 0.090 |
Why?
|
Immunoconjugates | 2 | 2014 | 981 | 0.090 |
Why?
|
Radiation Chimera | 1 | 2011 | 216 | 0.090 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1997 | 820 | 0.090 |
Why?
|
Myocarditis | 1 | 1999 | 802 | 0.090 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2011 | 55 | 0.090 |
Why?
|
School Health Services | 1 | 1995 | 387 | 0.090 |
Why?
|
Injections, Intraperitoneal | 3 | 2001 | 413 | 0.090 |
Why?
|
Thymus Gland | 3 | 2010 | 1261 | 0.090 |
Why?
|
Maleimides | 1 | 2011 | 112 | 0.090 |
Why?
|
Zymosan | 2 | 1988 | 128 | 0.090 |
Why?
|
Retina | 1 | 2001 | 2657 | 0.090 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2012 | 287 | 0.080 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 990 | 0.080 |
Why?
|
Flow Cytometry | 4 | 2014 | 5881 | 0.080 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2012 | 316 | 0.080 |
Why?
|
Adoptive Transfer | 2 | 2009 | 827 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2014 | 14448 | 0.080 |
Why?
|
beta Catenin | 2 | 2011 | 1043 | 0.080 |
Why?
|
Transduction, Genetic | 2 | 2010 | 898 | 0.080 |
Why?
|
Intracellular Space | 1 | 2010 | 198 | 0.080 |
Why?
|
Cells, Cultured | 6 | 2011 | 18973 | 0.080 |
Why?
|
Proteins | 2 | 2022 | 5995 | 0.080 |
Why?
|
Immunoglobulin G | 5 | 2003 | 4528 | 0.080 |
Why?
|
Chronic Disease | 5 | 2011 | 9347 | 0.070 |
Why?
|
Pulmonary Alveoli | 2 | 1988 | 664 | 0.070 |
Why?
|
Models, Animal | 3 | 2015 | 2120 | 0.070 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 2394 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 891 | 0.070 |
Why?
|
Coculture Techniques | 1 | 2011 | 1336 | 0.070 |
Why?
|
Cytokines | 4 | 2009 | 7421 | 0.070 |
Why?
|
Crosses, Genetic | 3 | 2003 | 752 | 0.070 |
Why?
|
Retroviridae | 1 | 2010 | 847 | 0.070 |
Why?
|
Serine | 1 | 2011 | 824 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2011 | 1752 | 0.070 |
Why?
|
Immunotherapy | 3 | 1999 | 4752 | 0.070 |
Why?
|
Immunization | 3 | 2011 | 1219 | 0.070 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 1624 | 0.070 |
Why?
|
Hepatovirus | 2 | 1997 | 45 | 0.070 |
Why?
|
Male | 21 | 2025 | 363698 | 0.070 |
Why?
|
Humans | 33 | 2024 | 765968 | 0.070 |
Why?
|
Female | 20 | 2020 | 396112 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2233 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1745 | 0.070 |
Why?
|
Catalase | 1 | 2006 | 216 | 0.060 |
Why?
|
Viral Hepatitis Vaccines | 2 | 1997 | 72 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2015 | 2058 | 0.060 |
Why?
|
Hepatitis A | 2 | 1997 | 126 | 0.060 |
Why?
|
Guinea Pigs | 3 | 1997 | 1300 | 0.060 |
Why?
|
Hypersensitivity, Delayed | 4 | 2011 | 490 | 0.060 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2005 | 54 | 0.060 |
Why?
|
Granulocytes | 1 | 1987 | 549 | 0.060 |
Why?
|
Phagocytosis | 1 | 2011 | 1520 | 0.060 |
Why?
|
Granuloma | 1 | 1987 | 327 | 0.060 |
Why?
|
Antibodies | 2 | 2003 | 2417 | 0.060 |
Why?
|
Pregnancy | 3 | 2020 | 30260 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1545 | 0.060 |
Why?
|
Catalysis | 1 | 2006 | 770 | 0.060 |
Why?
|
Lung Diseases | 1 | 2015 | 1940 | 0.060 |
Why?
|
Immunity | 1 | 1990 | 1002 | 0.060 |
Why?
|
Signal Transduction | 5 | 2011 | 23601 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 593 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2014 | 2098 | 0.050 |
Why?
|
Free Radicals | 3 | 1989 | 238 | 0.050 |
Why?
|
Graft vs Host Reaction | 1 | 2003 | 100 | 0.050 |
Why?
|
Lymphocytes | 1 | 2011 | 2599 | 0.050 |
Why?
|
Phosphorylation | 2 | 2011 | 8278 | 0.050 |
Why?
|
Antigens, Surface | 1 | 1987 | 1617 | 0.050 |
Why?
|
Indoles | 1 | 2011 | 1839 | 0.050 |
Why?
|
Maternal Behavior | 1 | 2005 | 306 | 0.050 |
Why?
|
Spleen | 3 | 2011 | 2296 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2006 | 1347 | 0.050 |
Why?
|
Autoantibodies | 1 | 2011 | 2113 | 0.050 |
Why?
|
Macrophages | 2 | 1988 | 5772 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3401 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2011 | 11641 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2001 | 511 | 0.050 |
Why?
|
Cornea | 3 | 2004 | 1316 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2002 | 268 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6493 | 0.050 |
Why?
|
Freund's Adjuvant | 1 | 2001 | 146 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4348 | 0.040 |
Why?
|
Polymorphism, Genetic | 2 | 2007 | 4247 | 0.040 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 438 | 0.040 |
Why?
|
Monocytes | 3 | 1994 | 2595 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2010 | 3404 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2003 | 839 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2002 | 608 | 0.040 |
Why?
|
Mice, Inbred DBA | 3 | 2011 | 623 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2006 | 1106 | 0.040 |
Why?
|
Blood Cells | 1 | 2002 | 307 | 0.040 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 113 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3715 | 0.040 |
Why?
|
Antilymphocyte Serum | 2 | 2015 | 493 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1801 | 0.040 |
Why?
|
Minor Histocompatibility Loci | 1 | 1999 | 16 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 3078 | 0.040 |
Why?
|
Primates | 2 | 2015 | 518 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2194 | 0.040 |
Why?
|
Cancer Vaccines | 1 | 2006 | 1044 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6113 | 0.040 |
Why?
|
Kinetics | 2 | 1999 | 6274 | 0.040 |
Why?
|
Histocompatibility Testing | 2 | 2015 | 726 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 2002 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2006 | 1884 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 1999 | 402 | 0.040 |
Why?
|
Bone Marrow | 1 | 1987 | 2921 | 0.030 |
Why?
|
Mutation | 2 | 2006 | 30198 | 0.030 |
Why?
|
DNA, Complementary | 1 | 2000 | 1984 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2000 | 2014 | 0.030 |
Why?
|
Membrane Glycoproteins | 3 | 2004 | 3690 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 1988 | 894 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2001 | 3454 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2001 | 995 | 0.030 |
Why?
|
Psychiatric Nursing | 1 | 1995 | 15 | 0.030 |
Why?
|
Lymphokines | 1 | 1998 | 911 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9443 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4165 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5696 | 0.030 |
Why?
|
Horses | 1 | 2015 | 293 | 0.030 |
Why?
|
Cross Reactions | 1 | 1996 | 824 | 0.030 |
Why?
|
Receptors, IgG | 2 | 1987 | 559 | 0.030 |
Why?
|
Ligands | 1 | 2001 | 3273 | 0.030 |
Why?
|
Cell Transplantation | 1 | 1995 | 473 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 226 | 0.030 |
Why?
|
Professional Misconduct | 1 | 1994 | 73 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 1991 | 1415 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1652 | 0.030 |
Why?
|
Protein Binding | 2 | 2014 | 9296 | 0.030 |
Why?
|
Scientific Misconduct | 1 | 1994 | 77 | 0.030 |
Why?
|
Genes, MHC Class II | 1 | 1994 | 433 | 0.030 |
Why?
|
Inflammation | 2 | 2015 | 10850 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 705 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1991 | 822 | 0.020 |
Why?
|
Blood | 1 | 1994 | 597 | 0.020 |
Why?
|
Risk Factors | 3 | 2015 | 74840 | 0.020 |
Why?
|
Blood Group Incompatibility | 1 | 2011 | 134 | 0.020 |
Why?
|
Superoxides | 1 | 1991 | 383 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2120 | 0.020 |
Why?
|
Cell Division | 2 | 2002 | 4475 | 0.020 |
Why?
|
Leukemia, T-Cell | 1 | 1989 | 102 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13648 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2000 | 4772 | 0.020 |
Why?
|
Rats | 2 | 2006 | 23707 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 414 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10729 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1991 | 545 | 0.020 |
Why?
|
Mice, SCID | 2 | 2004 | 2630 | 0.020 |
Why?
|
Biopsy | 2 | 2012 | 6763 | 0.020 |
Why?
|
Rosette Formation | 1 | 1987 | 152 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4618 | 0.020 |
Why?
|
Lectins | 1 | 1989 | 487 | 0.020 |
Why?
|
Cell Line | 4 | 2014 | 15543 | 0.020 |
Why?
|
Acrylic Resins | 1 | 1987 | 131 | 0.020 |
Why?
|
Immunoglobulin Isotypes | 1 | 1987 | 157 | 0.020 |
Why?
|
HIV | 1 | 1994 | 1585 | 0.020 |
Why?
|
Base Sequence | 2 | 2014 | 12403 | 0.020 |
Why?
|
Acute Disease | 2 | 2011 | 7232 | 0.020 |
Why?
|
Pilot Projects | 2 | 2015 | 8733 | 0.020 |
Why?
|
Time Factors | 3 | 2004 | 40065 | 0.020 |
Why?
|
Gamma Rays | 1 | 1988 | 324 | 0.020 |
Why?
|
Gammaproteobacteria | 1 | 2006 | 28 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 6942 | 0.020 |
Why?
|
Isotopes | 1 | 2006 | 124 | 0.020 |
Why?
|
Vaccines, Inactivated | 2 | 1997 | 185 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1997 | 3211 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2006 | 310 | 0.020 |
Why?
|
GATA3 Transcription Factor | 1 | 2006 | 163 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2203 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6309 | 0.010 |
Why?
|
Epitope Mapping | 1 | 2006 | 300 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1349 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1657 | 0.010 |
Why?
|
Kidney | 2 | 2011 | 7066 | 0.010 |
Why?
|
Clonal Anergy | 1 | 2004 | 169 | 0.010 |
Why?
|
Antigens, CD | 2 | 2004 | 4025 | 0.010 |
Why?
|
Busulfan | 1 | 2003 | 264 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2003 | 1377 | 0.010 |
Why?
|
Immune Sera | 1 | 2001 | 601 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3449 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 2001 | 249 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1987 | 1870 | 0.010 |
Why?
|
Point Mutation | 1 | 2006 | 1590 | 0.010 |
Why?
|
STAT4 Transcription Factor | 1 | 2000 | 94 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5747 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2006 | 1183 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2000 | 197 | 0.010 |
Why?
|
Tacrolimus | 1 | 2003 | 753 | 0.010 |
Why?
|
Transgenes | 1 | 2003 | 1015 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13024 | 0.010 |
Why?
|
Adipocytes | 1 | 2006 | 1194 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10429 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2001 | 919 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2003 | 2669 | 0.010 |
Why?
|
Antibody Formation | 1 | 2002 | 1391 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 1679 | 0.010 |
Why?
|
Oxygen | 1 | 1989 | 4241 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 2060 | 0.010 |
Why?
|
Hepatitis A Vaccines | 1 | 1997 | 26 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2007 | 8041 | 0.010 |
Why?
|
Neoplasms | 1 | 2006 | 22340 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2395 | 0.010 |
Why?
|
Lung | 1 | 2015 | 10033 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 1870 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2717 | 0.010 |
Why?
|
Immunogenetics | 1 | 1995 | 62 | 0.010 |
Why?
|
Consumer Product Safety | 1 | 1995 | 121 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4908 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16721 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2006 | 11888 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2006 | 3584 | 0.010 |
Why?
|
France | 1 | 1994 | 495 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2631 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2003 | 3096 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11022 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18293 | 0.010 |
Why?
|
DNA | 1 | 2006 | 7202 | 0.010 |
Why?
|
Ionomycin | 1 | 1991 | 109 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11206 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2006 | 12768 | 0.010 |
Why?
|
Trans-Activators | 1 | 2000 | 2850 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1994 | 1243 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1994 | 1132 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1995 | 1731 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39193 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1991 | 340 | 0.010 |
Why?
|
Adolescent | 2 | 1995 | 88835 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1994 | 1612 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14652 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1991 | 1528 | 0.000 |
Why?
|
Disulfides | 1 | 1988 | 462 | 0.000 |
Why?
|
Molecular Weight | 1 | 1988 | 2163 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1724 | 0.000 |
Why?
|
Protein Processing, Post-Translational | 1 | 1993 | 1957 | 0.000 |
Why?
|
Binding Sites | 1 | 1993 | 6001 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20124 | 0.000 |
Why?
|
Staphylococcus aureus | 1 | 1991 | 1424 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9601 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1994 | 5786 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29922 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2002 | 65188 | 0.000 |
Why?
|
Middle Aged | 1 | 1995 | 223009 | 0.000 |
Why?
|
Adult | 1 | 1995 | 223044 | 0.000 |
Why?
|